ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzumab Govitecan +/- Pembro in MIBC" | VuMedi

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ecancer

ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzumab Govitecan +/- Pembro in MIBC"

By ecancer FEATURING Antonio Cigliola

By ecancer FEATURING Antonio Cigliola

37 views

June 20, 2024

0 Comments

Login to view comments. Click here to Login